Top Markets
#1 Siren Siren +38.57%
#2 RedStone RedStone +23.03%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.68%
#4 Cysic Cysic +15.54%
#5 Ocean Protocol Ocean Protocol +15.53%
#6 Verus Coin Verus Coin +13.51%
#7 Arowana Arowana +13.51%
#8 KUB Coin KUB Coin +13.09%
#9 Perle Perle +12.59%
#10 Wiki Cat Wiki Cat +9.55%
Coin of the day
Siren Siren
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Antibe Therapeutics Inc. Antibe Therapeutics Inc.

Antibe Therapeutics Inc.

ATE
Rang in aandelen #32096
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
Aandeelprijs
$0.21483059
Laatst gesynchroniseerd: 2024-05-07
Marktkapitalisatie
$11.13M
Verandering (1 dag)
0.34%
Verandering (1 jaar)
0.00%
Land
CA
Handel Antibe Therapeutics Inc. (ATE)

Categorie

Healthcare
P/B-ratio voor Antibe Therapeutics Inc. (ATE)
P/B-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Antibe Therapeutics Inc. is de huidige P/B-ratio (TTM) 0. Eind 2026 had het bedrijf een P/B-ratio van 0.
P/B-ratiohistoriek voor Antibe Therapeutics Inc. van 2026 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 3.7944 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 5.423 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 2.0146 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 3.072 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 4.9725 -
US